Q&A with IVI’s Executive Director, Jennifer Bright

Ms. Bright brings over two decades of health care policy, issue management, patient advocacy, and executive leadership to the role. She is also founder and President of Momentum Health Strategies and has formerly served as executive director of the Society for Healthcare Epidemiology of America, representing physician, advanced practice nurse, and researcher [...]

2021-06-15T14:11:24-06:00June 15th, 2021|Blog|

Questions about the IVI-MDD Model Scope

On Monday, May 3, IVI, along with Jessica Kennedy from Mental Health America and Mohannad Kusti from Pivot Onsite-Innovations, held an informational webinar on the draft model scope for IVIs's upcoming economic model on major depressive disorder (MDD). To prime the pump for your own comments and feedback, we're sharing some of the questions and [...]

2021-05-07T16:05:24-06:00May 7th, 2021|Blog|

IVI MEMBER SPOTLIGHT: The Alliance for Aging Research

In late January, we sat down with Michael Ward from of IVI's newest members, The Alliance for Aging Research. We are so pleased to partner with such a dynamic organization.       Thank you so much for speaking with us today. Could you tell us a little bit about the Alliance for Aging Research? [...]

2021-02-22T11:33:23-06:00February 22nd, 2021|Blog, IVI News, Member Spotlight|

Looking Ahead to 2021: Let’s Really Make 2021 the Year of the Patient

Author: Jennifer Bright, MPA, Executive Director, IVI The promise of a new year offers an opportunity to recall our best moments in 2020 (surely there are a few!) and get excited for what's ahead. For IVI, I've been thinking about the accomplishments not just in 2020, but in the three years since I joined this [...]

2020-12-23T11:29:46-06:00December 23rd, 2020|Blog|


Earlier this fall, we sat down with Andrea Maresca, an IVI Board Member, who recently joined our organization. We are thrilled to have an expert in federal and state healthcare policy as part of our organization.       Tell us a little about your background and how you came to be connected with IVI. [...]

2020-12-10T14:14:24-06:00December 10th, 2020|Blog, IVI News, Member Spotlight|


For our first Member Spotlight, we chatted with Dr. Wayne Burton about what he sees as the future of value assessment. Dr. Burton has been with IVI almost since its inception. This interview is an adaptation of a conversation we had with Dr. Burton this fall.     Tell us a little about yourself and [...]

2020-12-10T11:27:11-06:00September 29th, 2020|Blog, IVI News, Member Spotlight|

Tackling Hard Questions in Value

Author: Jennifer Bright, MPA, Executive Director, IVI For decades, we've known that untreated or poorly treated Major Depressive Disorder (MDD) is an enormous burden on individual patients, our health care system, and our society. Despite having this knowledge, there is much work to do in order to support and optimize cost-effective care for patients suffering [...]

2020-12-29T17:01:00-06:00September 9th, 2020|Blog|

Exploring Patient Heterogeneity and Diversity in Treatment Responses

Author: Jennifer Bright, MPA Everyone hopes for a COVID vaccine so our lives can return to normal. Yet, we know that even if clinical trials prove a vaccine's effectiveness, our society will still have to endure a long process of distribution. I'm personally willing to wait for a vaccine for healthcare workers, the elderly, and [...]

2020-12-29T17:01:22-06:00August 20th, 2020|Blog|

How do we identify and measure value for patients with rare diseases?

Authors: Annie Kennedy and Joff Masukawa. Rare diseases impact 1 in 10 Americans, and over 400 million people worldwide. The current development and FDA approval process can cost hundreds of millions of dollars – and take an average of 15 years – to develop one therapy. For the 30% of children diagnosed with a rare [...]

2020-12-29T17:01:46-06:00July 22nd, 2020|Blog|
Go to Top